Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Agios Pharmaceuticals Inc (AGIO)  
$35.00 0.18 (0.51%) as of 4:30 Thu 5/16


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 69,110,000
Market Cap: 2.42(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $19.97 - $34.81
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Agios Pharmaceuticals is a biopharmaceutical company focused on improving patients' lives in the field of cellular metabolism and adjacent areas of biology, with the goal of creating molecule medicines for genetically defined diseases (GDD). The lead product in its GDD, portfolio, PYRUKYND® (mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the potential treatment of hemolytic anemias. Co. is evaluating PYRUKYND® for the treatment of a- and B-thalassemia and sickle cell disease (SCD). Co. is also developing AG-946, a PK activator, for the potential treatment of hemolytic anemias and other indications, including SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 165,005 218,053 292,572 410,176
Total Sell Value $5,507,764 $6,694,407 $8,693,794 $11,787,151
Total People Sold 8 9 9 9
Total Sell Transactions 14 28 39 48
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 822
  Page 17 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bowden Christopher Chief Medical Officer   •       –      –    2018-03-14 4 AS $82.23 $164,661 D/D (2,000) 881     -
   Bowden Christopher Chief Medical Officer   •       –      –    2018-03-14 4 OE $35.16 $70,320 D/D 2,000 2,881     -
   Biller Scott Chief Scientific Officer   •       –      –    2018-03-05 4 AS $80.93 $249,229 D/D (3,000) 53,059     -
   Biller Scott Chief Scientific Officer   •       –      –    2018-03-05 4 OE $9.05 $27,150 D/D 3,000 56,059     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-03-01 4 AS $80.38 $1,054,218 D/D (13,000) 0     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-03-01 4 OE $0.30 $3,933 D/D 13,000 13,000     -
   Hoerter Steven L. Chief Commercial Officer   •       –      –    2018-02-22 4 AS $78.63 $161,192 D/D (2,050) 0     -
   Hoerter Steven L. Chief Commercial Officer   •       –      –    2018-02-22 4 OE $39.76 $81,508 D/D 2,050 2,050     -
   Bowden Christopher Chief Medical Officer   •       –      –    2018-02-16 4 AS $77.51 $155,305 D/D (2,000) 881     -
   Bowden Christopher Chief Medical Officer   •       –      –    2018-02-16 4 OE $35.16 $70,320 D/D 2,000 2,881     -
   Biller Scott Chief Scientific Officer   •       –      –    2018-02-05 4 AS $74.89 $228,128 D/D (3,000) 53,059     -
   Biller Scott Chief Scientific Officer   •       –      –    2018-02-05 4 OE $0.47 $26,601 D/D 3,000 56,059     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-02-01 4 AS $78.50 $1,023,756 D/D (13,000) 0     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-02-01 4 OE $0.30 $3,933 D/D 13,000 13,000     -
   Bowden Christopher Chief Medical Officer   •       –      –    2018-02-01 4 AS $78.50 $157,500 D/D (2,000) 881     -
   Bowden Christopher Chief Medical Officer   •       –      –    2018-02-01 4 OE $35.16 $70,320 D/D 2,000 2,881     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-01-26 4 AS $80.35 $1,911,494 D/D (23,572) 0     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-01-26 4 OE $0.30 $7,131 D/D 23,572 23,572     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-01-24 4 AS $80.01 $1,600 D/D (20) 0     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-01-24 4 OE $0.30 $6 D/D 20 20     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-01-24 4 AS $80.01 $1,082,775 D/D (13,533) 0     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-01-24 4 OE $0.30 $4,094 D/D 13,533 13,533     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-01-23 4 AS $80.01 $2,630,329 D/D (32,875) 0     -
   Schenkein David P Chief Executive Officer   •       •      –    2018-01-23 4 OE $0.30 $9,945 D/D 32,875 32,875     -
   Hoerter Steven L. Chief Commercial Officer   •       –      –    2018-01-23 4 AS $74.83 $1,870,750 D/D (25,000) 0     -
  822 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 17 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us